Clinical Trials Browser

INDUSTRY × Interventional × Unspecified Adult Solid Tumor, Protocol Specific × Clear all

NCT04842630 2024-02-09

A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Phase 1 Terminated

11 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT03859752 2023-09-22

TR1801-ADC in Patients With Tumors That Express c-Met

Phase 1 Suspended

15 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT02869295 2021-07-29

NKTR-214

Phase 1/2 Completed

28 enrolled 16 charts

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003713 2018-08-29

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Completed

35 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003822 2018-08-29

SR-45023A in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004049 2018-08-29

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004927 2017-01-30

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01418677 2016-05-17

An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Phase 1 Completed

19 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00607724 2015-10-08

GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

68 enrolled 22 charts

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01560325 2015-09-16

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Phase 1 Completed

21 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00550927 2013-05-15

Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer

Phase 1 Completed

42 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003403 2013-04-23

GPX-100 in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00349167 2012-11-30

PR-104 in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

27 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00077077 2012-05-16

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01028859 2011-12-22

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Phase 1 Completed

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00616213 2011-06-01

PR104 and G-CSF in Treating Patients With Solid Tumors

Phase 1 Completed

5 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01358227 2011-05-24

A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

Phase 1 Completed

26 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00459836 2011-03-02

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

Phase 1 Completed

42 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific